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Abstract.  Occludin  is an integral  membrane protein 
localizing  at tight junctions  (TJ) with  four transmem- 
brane domains and a  long COOH-terminal  cytoplas- 
mic domain (domain  E) consisting  of 255 amino 
acids.  Immunofluorescence  and laser scan microscopy 
revealed that chick full-length  occludin introduced  into 
human  and bovine epithelial  cells was correctly deliv- 
ered to and  incorporated  into preexisting  TJ.  Further 
transfection  studies with various deletion mutants 
showed that the domain E,  especially its COOH- 
terminal  ,~150 amino acids (domain  E358/504),  was 
necessary for the localization  of occludin at TJ.  Sec- 
ondly, domain E  was expressed in Escherichia  coli as 
a  fusion protein with glutathione-S-transferase,  and 
this fusion protein  was shown to be specifically bound 
to a complex of ZO-1  (220 kD) and  ZO-2  (160 kD) 
among various membrane peripheral  proteins.  In vitro 
binding  analyses using glutathione-S-transferase  fusion 
proteins of various deletion mutants  of domain E  nar- 
rowed down the sequence necessary for the ZO-1/ZO-2 
association into the domain E358/504.  Furthermore, 
this  region directly associated with the recombinant 
ZO-1  produced in E.  coli. We concluded that  occludin 
itself can localize at TJ and directly associate with 
ZO-1.  The coincidence of the sequence necessary for 
the ZO-1  association with that for the TJ localization 
suggests that the association with underlying  cyto- 
skeletons through  ZO-1  is required  for occludin to be 
localized at TJ. 
T 
HE  establishment  of compositionaUy  distinct  fluid 
compartments by epithelium and endothelium is cru- 
cial for the development and function of most organs. 
Tight  junction  (TJ),~ an  element  of  epithelial  and  en- 
dothelial junctional  complexes,  is directly involved in this 
compartmentation by sealing cells to create the primary bar- 
rier to the diffusion of solutes through the paracellular path- 
way  (Schneeberger  and  Lynch,  1992;  Gumbiner,  1987, 
1993). TJ also functions as a boundary between the apical 
and basolateral plasma membrane domains, which differ in 
proteins, lipid composition, and physiological functions, to 
create and maintain epithelial and endothelial cell polarity 
(Rodriguez-Boulan  and  Nelson,  1989).  Therefore,  TJ has 
been attracting  increasing  interest among cell biologists. 
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Accumulating evidence has shown that some unique pro- 
teins constitute TJ (Anderson et al.,  1993; Citi,  1993). The 
first protein identified as a TJ constituent was ZO-1  with a 
molecular mass of 220 kD (Stevenson et al., 1986; Anderson 
et al.,  1988). This protein is a peripheral membrane protein 
that  is  localized  in  the  immediate  vicinity  of the plasma 
membrane of TJ in epithelial and endothelial cells (Steven- 
son et al., 1986,  1989), whereas it is colocalized with cadhe- 
rins in cells lacking TJ, such as fibroblasts and cardiac mus- 
cle cells  (Itoh  et al.,  1991,  1993;  Howarth  et al.,  1992; 
Tsukita et al.,  1992), with some exceptions (Howarth et al., 
1994). As a ZO-l-binding protein,  another peripheral pro- 
tein called ZO-2 with a molecular mass of 160 kD has been 
identified (Gumbiner et al.,  1991).  Unlike ZO-1, the distri- 
bution of this protein is restricted to TJ (Jesaitis and Good- 
enough,  1994).  Both ZO-1  and ZO-2 reportedly show se- 
quence similarity  to the product of lethal  (1) discs large-1 
(dig), one of the tumor suppressor molecules in Drosophila 
(Itoh et al.,  1993; Tsukita et al.,  1993; Willott et al.,  1993; 
Jesaitis and Goodenough,  1994).  In addition to ZO-1  and 
ZO-2, two other TJ-specific peripheral membrane proteins 
have been so far identified;  cingulin  and the 7H6 antigen 
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more distantly from the membrane than ZO-1 (Stevenson et 
al.,  1989;  Zhong et al.,  1993). 
To clarify the structure and function of TJ at the molecular 
level, an integral membrane protein working at TJ should be 
identified. However, this integral membrane component re- 
mained elusive for quite some time.  Most recently, using 
mAbs, we identified an integral membrane protein named 
occludin that was exclusively localized at TJ both in epi- 
thelial and endothelial cells (Furuse et al., 1993). The follow- 
ing structural characteristics of occludin molecules were 
clarified by eDNA cloning and sequencing (see Fig. 2). (a) 
In the NH2-terminal half, occludin contains four transmem- 
brane domains that segment the molecule into five domains 
(domains A-E). (b) A COOH-terminal half (domain E) con- 
sisting of '~ 250 amino acid residues resides in cytoplasm. 
(c) Charged amino acids mostly locate at domain E. (d) The 
content of tyrosine and glycine residues is very high in the 
extracellular domains (domains B and D). 
Since occludin has been identified and its eDNA has been 
obtained, the following issues on the structure of TJ require 
resolution: how the newly synthesized occludin molecules 
are delivered and localized at'13; how occludin interacts with 
TJ-specific peripheral proteins such as ZO-1 and ZO-2; and 
whether or not the TJ strand is composed solely of occludin 
molecule. While studying these issues, we identified the im- 
portance of the COOH-terminal cytoplasmic domain (do- 
main E) of occludin molecules. In this study, we showed that 
chick occludin introduced into human and bovine epithelial 
cells was correctly delivered to and localized at TJ, and that 
domain E of occludin was necessary for the localization of 
the newly synthesized oceludin at TJ. In vitro binding using 
glutathione-S-transferase (GST)-domain E fusion protein re- 
vealed that occludin directly bound to ZO-1, and that domain 
E was necessary for the occludin-ZO-1 association. Further- 
more, we narrowed down the sequences necessary for TJ lo- 
calization and ZO-1 association, and found that both se- 
quences fell within the same region in domain E. We believe 
that this type of study will lead to further understanding of 
the structure and functions of TJ at the molecular level. 
Materials and Methods 
Cells and Antibodies 
Madin-Darby bovine kidney (MDBK) cells and human intestinal epithelial 
cells (I"84) were obtained from the Japanese Cancer Research  Resources 
Bank (Tokyo, Japan) and the American Type Culture Collection (Rockville, 
MD), respectively. Human esophagus fibroblast primary culture cells (PF- 
7N) were provided by Dr. T. Iwazawa (Osaka University). MDBK and PF- 
7N cells were grown in Dulbecco's modified Eagle's medium supplemented 
with 10% FCS. "['84  cells  were grown in a I:I mixture of Dulbecco's 
modified Eagle's  medium and Ham's F-12  medium supplemented with 
5% FCS. 
Rat anti-chicken occludin mAb (Oc-2) and mouse anti-rat ZO-I mAbs 
(1'8-754, "1'8-109)  were obtained and characterized as described (Itoh et al., 
1991; Furuse et al.,  1993). Rabbit anti-ZO-2 pAb (R9989)  was provided 
by Dr. D. Goodenough (Harvard  Medical School,  Boston, MA). Mouse 
anti-c-myc  mAb was purchased  from Oncogene Science  Inc.  (Manhasset, 
NY). Rabbit anti-bovine  brain spectrin pAb was purchased from Chemicon 
International, Inc.  (Temecula,  CA). 
Occludin Expression Constructs and Mutants 
The expression plasmid (pBATOC) of full-length  occludin driven by the 
chick /3-actin promoter was  constructed using two  plasmids,  pX1  and 
pBATEM2.  To construct pXl, occludin cDNA containing the whole open 
reading frame was constructed by combining two cDNA fragments, FHI-14 
and FH2-9,  at the BglII site (Furuse et al.,  1993), and then it was cloned 
into the EcoRI site of pBluescript SK(-).  The BglII-SalI  fragment of 
pBATEM2 (E-cadherin expression vector; Nose et al.,  1988) that encodes 
full-length E-cadherin was replaced  with the BamHI-SalI  !.6-kb fragment 
obtained from pX1 to construct pBATOC. 
An epitope tag of the partial sequence of c-myc (EQKLISEEDL)  was 
linked to the COOH-terminal end of full-length or mutant occludin.  For this 
purpose, we used a plasmid pCMYCB that was constructed by N. Funayama 
(National Institute for Physiological Sciences,  Okazaki,  Japan) as follows. 
An ollgonucleotide encoding EQKLISEEDL followed with two stop cnduns 
and its complement oligonucleotide  were synthesized  and annealed.  The 
EcoRI-EcoRV fragment of pBluescript SK(-) was replaced with this DNA 
fragment to produce pCMYCB. 
Expression plasmids for full-length or mutant occlndin with c-myc tag 
were constructed as follows (see Fig. 2). DNA fragments encoding the en- 
tire domain E of occludin or its deletion mutants were produced by PCR 
using appropriate primers. Using pCMYCB, the oligonucleotide  encoding 
c-myc tag was linked to each PCR product.  A fragment between BglH (I!e- 
255) and SalI (3' noncoding region)  sites in pBATOC were replaced  with 
each c-myc-tagged  fragment from pCMYCB. 
Proteins expressed by these constructs have an additional Glu-Ser before 
the c-myc tag.  Furthermore, rnOc/dN358  and mOc/d(445-474)  products 
have additional Glu-Arg-Ser and Glu-Ser at their  deletion sites, respectively. 
All DNA fragments in the plasmids amplified by PCR were sequenced using 
the Taq DyeDeoxy  TM Terminator cycle Sequencing Kit (Applied Biosystems, 
Inc., Foster City, CA) to insure that no errors were introduced during PCR 
amplification. 
DNA Transfections 
MDBK and PF-7N cells were transfected  with DNA using Lipofectin and 
Lipofectamine,  respectively  (GIBCO BRL, Gaithersburg, MD). Cells cul- 
tured on coverslips were washed once with Opti-MEM (GIBCO BRL), and 
were incubated for 5 h with 1 ml of Opti-MEM containing 1/zg of plasmid 
DNAs and 10/~1  of the reagents, followed by the addition of 3 ml of normal 
medium containing FCS.  Cells were then cultured until observation. 
When TM cells were transfected with DNA, the efficiency was improved 
by culturing the cells for >48 h on coverslips  in Eagle's MEM containing 
50/~M Ca  2+ (LCM) in the presence of 5% FCS dialyzed  against saline. 
Transfection  was  performed using Lipefectamine as described above in 
LCM and saline-dialyzed  FCS instead of Opti-MEM and normal FCS, 
respectively. 24 h after transfection,  the medium was replaced with the nor- 
mal medium. 
Immunofluorescence Microscopy and Laser 
Scan Microscopy 
Indirect  immunofluorescence  microscopy  of transfected  cells  was  per- 
formed as described previously  (Itoh et al.,  1991; Tsukita et al.,  1989). 
Briefly, ,,o48 h after transfection,  cells were fixed with 1% formaldehyde in 
PBS for 10 rain, followed by soaking in 0.2% Triton X-100 in PBS for 10 
rain. The second antibodies were F1TC-conjngated goat anti-rat IgG (Tago 
Inc., Burlingame,  CA) for Oc-2,  rhndamine-conjugated  goat anti-mouse 
IgG (Chemicon International, Inc.) for T8-754, and FITC-conjugated  sheep 
anti-mouse IgG (Amersham International PLC, Bucks, UK) for anti-c-myc 
mAb. Samples  were examined using a fluorescence  microscope,  an Ax- 
iophot photomicroscope, or a laser scan microscope LSM310 (Carl Zeiss, 
Inc., Thornwood, NY). 
Generation  of Fusion Proteins 
Occludin-domaln E full-length  or mutant cDNAs obtained by PCR were 
introduced  into pGEX vectors,  pGEX-2T  or pGEX-3X  (Pharmacia Fine 
Chemicals, Piscataway, N  J), to express fusion proteins with GST in Esche- 
richia  coli (see Fig. 5).  All constructs,  except plasmids for GST-OcE and 
GST-OcE/dN358, have an additional Glu-Phe-Ile-Val-Thr-Asp derived from 
pGEX vectors at their COOH-terminal ends of fusion proteins.  Fusion pro- 
teins expressed by a plasmid for GST-OcE/d (445-474) have another addi- 
tional Glu-Phe at its deletion site. All DNA fragments amplified by PCR 
were sequenced to insure that no errors were introduced during PCR am- 
plification. Fusion proteins were produced in E. coil (XL-1/Blne) from these 
constructs, according to the procedure described by the manufacturer. 
The fusion protein of mouse ZO-I with maltose-binding protein (MBP) 
was produced  using an F22 fragment (190-1235 aa) in pMAL-CRI (New 
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In Vitro Binding Assay 
In vitro binding assays were performed using a column. Cultures ofE. coli 
expressing GST-fusion proteins (100 ml) were collected by brief centrifuga- 
tion and resuspended in 6 ml of solution K (140 mM KCI, 10 mM Hepes 
[pH 7.5],  1 mM MgCI2,  2 #g/rnl leupeptin, and 1 mM p-amidinophenyl 
methanesulfonyl fluoride hydroehloride [pAPMSF]). After sonication and 
centrifugation at  10,000  g  for  10 min, the supernatant was applied to a 
column  containing  glntathione-Sepharose  4B  beads  (Pharrnacia  Fine 
Chemicals), which was washed with 20 vol of solution K. Thereafter, the 
low salt extract of chick junctional fraction or high salt extract of MDBK 
ceils (see below) was applied onto the column. After washing with 40 vol 
of solution K, bound proteins were eluted with 50 mM Tris-HCl buffer (pH 
8.0) containing 10 mM glutathione. 0.8-ml fractions were collected. Since 
almost all the bound proteins were eluted within the first five fractions, they 
were mixed and used for SDS-PAGE and immunoblotting. 
To detect ¢-spectrin or MBP-ZO-1  fusion protein, binding assays were 
performed by means of the batch method. GST-fusion proteins of oecludin 
were incubated with glutathione beads at 40C for I h. After five washes with 
10 vol of solution K by brief centrifugation, the beads were incubated with 
the high salt extract of  MDBK ceils or the extract ofE. coli containing MBP- 
ZO-I fusion protein at 4°C for 1 h. The beads were then washed five times 
with solution K, and the excess solution was removed. Bound proteins were 
released from beads with SDS-PAGE sample buffer. 
The low salt extract of chick junctional fraction was prepared as de- 
scribed previously (Furuse et al.,  1993;  Tsukita  and Tsukita,  1989).  The 
extract from '~40 chicks was used in one experiment. The low salt extract 
was freeze dried and resolved in 1 ml of solution K, followed by centrifuga- 
tion at 100,000 g for 1 h. The supernatant was used for the binding assay. 
The high salt extract of MDBK cells was prepared according to the method 
for purifying ZO-1  from mouse brain,  as described (Itoh et al.,  1991). 
Confluent MDBK cells from two 15-cm dishes were scraped and collected 
by brief centrifugation. They were homogenized in 1 mM NaHCO3 or in 
solution K with tight-fitting Dounce homogenizer, followed by centrifuga- 
tion at 100,000  g for 1 h. The pellet was resuspended by sonication in 1 
ml of 10 mM Hepes buffer (pH 7.5) containing 1 M KC1, 1 mM EGTA, 
2 #g/ml leupeptin, and 0.5 mM PMSF, and was then incubated on ice for 
1 h. After centrifugation at 100,000  g for 1 h, the supernatant was diluted 
with 10 mM Hepes buffer (pH 7.5) at a final concentration of 140 mM KC1. 
Aggregated proteins were removed by centrifugation at 10,000 g for 10 min, 
and the supernatant was used for the binding assay. The extract containing 
MBP-ZO-1  fusion protein was prepared by the same procedure as that for 
GST-occludin fusion proteins. 
Gel Electrophoresis  and Immunoblotting 
One-dimensional SDS-PAGE (12.5%  gel)  was based on the method of 
Laemmli (1970).  Gels were stained with Coomassie brilliant blue R-250 or 
by using a silver staining kit (Wako Pure Chemical Industries, Osaka, Ja- 
pan).  For immunoblotting, proteins separated by SDS-PAGE were elec- 
trophoretically transferred to nitrocellulose sheets, which were then in- 
cubated with the antibodies. The antibodies were detected with a blotting 
detection kit (Amersham). 
Results 
Localization of Chick Occludin Expressed by a 
Full-length cDNA at Tight Junctions in Human and 
Bovine Epithelial Cells 
Chick occludin eDNA clones were isolated and sequenced 
(Furuse et al.,  1993). To construct the expression vector, a 
1.6-kb eDNA encoding full-length occludin was assembled 
from two overlapping clones. This eDNA encodes a 55.9 kD 
occludin polypeptide (Furuse et al.,  1993).  The complete 
eDNA was subcloned into a mammalian expression vector 
driven by the/3-actin promoter, which was then introduced 
into cultured cells. 
The bovine and human epithelial cell lines, MDBK and 
T84, were selected for our transfection studies. Both types 
of cells bear the typical junctional complex including TJ at 
the most apical portion of the lateral membranes. To detect 
the transiently expressed chick occludin by immunofluores- 
cence microscopy, we used the rat anti-chick occludin mAb 
Oc-2, which did not recognize human and bovine occludin 
(Furuse et al.,  1993). 
MDBK  cells  transfected  with  plasmids  encoding  full- 
length occludin displayed a characteristic pattern of fluores- 
cence.  In  addition  to  the  diffuse  staining  at  perinuclear 
cytoplasm, the concentration of expressed chick occludin 
was detected in a linear fashion at the cell-cell border (Fig. 
1 a). When the transfectants were doubly stained with anti- 
occludin mAb and anti-ZO-1  mAb,  ZO-1  appeared to be 
colocalized with the expressed chick occludin concentrated 
at the cell-cell border (Fig.  1 b).  Therefore, to precisely 
compare the distribution of occludin with that of ZO-1, we 
analyzed the doubly stained 1"84 transfectants by laser scan 
microscopy (Fig.  1, c and d).  As shown in Fig.  1, e and f 
as overlaid computer-generating cross-sectional images, the 
expressed chick occludin and ZO-1 were precisely colocal- 
ized at the most apical region of lateral membranes. In our 
laser scan microscopy system, tight and adherens junctions 
can be resolved (Yonemura et al., 1994). All these observa- 
tions together led us to the conclusion that the expressed 
chick occludin was correctly delivered to and concentrated 
at TJ in human and bovine epithelial cells. 
The question naturally arose as to whether or not occludin 
expressed in nonepithelial cells lacking TJ were delivered to 
cell-cell contact sites.  Chick occludin was then introduced 
into the human fibroblast PF-7N. As reported Otoh et al., 
1993),  ZO-1  was concentrated at cell-cell contact sites in 
fibroblasts.  The introduced occludin was  concentrated at 
some of these ZO-l-enriched cell-cell contact sites in cells 
expressing a large amount of occludin (Fig.  1, g and h). 
Sequences in the COOH-terminal Cytoplasmic 
Domain of Occludin Necessary for Localization  at 
Tight Junctions 
To analyze the role of the COOH-terminal cytoplasmic do- 
main of occludin molecules (domain E; amino acid residues 
250-504) in their localization at TJ, we performed transfec- 
tions  with  various domain E  deletion mutants.  Since the 
efficiency of transfection was significantly higher in MDBK 
than in "1"84  cells, we used the former in the following mutant 
occludin expression studies. We designed an expression vec- 
tor with two major considerations. Immunofluorescence mi- 
croscopy would be used and the sequences encoding the anti- 
genic determinant of  the protein should not be lost during the 
construction of deletion mutants. To accomplish these goals, 
a 30-bp sequence encoding a portion of c-myc was added to 
the 3' end of each eDNA construct, allowing us to detect the 
expressed protein by anti-c-myc mAb. 
To narrow down the sequence necessary for the TJ local- 
ization of occludin from both COOH-  and  NH2-terminal 
sides,  we  constructed  several  COOH-  or  NH:-terminal 
truncations of domain E from full-length occludin with the 
c-myc epitope on their COOH-terminal end  (Fig.  2).  As 
shown in Fig.  3 a,  the c-myc-tagged, full-length occludin 
(mOc)  was  transiently  expressed  and  localized  at  TJ  in 
MDBK cells, indicating that the tag peptide did not interfere 
Furuse et al. Functions of the Occludin  Carboxyl-terminal  Domain  1619 Figure L  Subcellular distribution of chick full-length occludin in transient transfectants. Bovine and human epithelial cells, MDBK (a 
and b) and 1"84 (c-f), respectively, or human fibroblasts, PF-7N (g and h) were transfected with plasmids encoding full-length occludin~ 
and were then doubly stained with anti-chick occludin mAb, Oc-2 (a,  c, e,  and g) and anti-rat ZO-1 mAb, T8-754 (b, d, f, and h). 
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c-myc epitope on their COOH-terminal  end (m). Occludin is seg- 
mented into five domains (A-E) by four transmembrane  domains, 
and both COOH- and NH2-terminal truncations of domain E from 
full-length occludin were constructed. 
with the concentration of occludin at TJ. All COOH-terminal 
truncations  constructed  here  (mOc/dC474,  mOc/dC444, 
mOc/dC414, and mOc/dC357) failed to localize at TJ (Fig. 
3, b-e), indicating that the responsible sequence could not 
be narrowed down from the COOH side.  By contrast,  the 
NH2-terminal truncation, mOc/dN358, was clearly concen- 
trated at TJ, although its localization efficiency was rather 
lower  than  that  of  mOc  (Fig.  3  f).  The  further  NH2- 
terminal truncation, mOc/dN387, was by no means localized 
at TJ (Fig.  3 g). 
Taking all these results together, we concluded that amino 
acid residues 358-504  (domain E358/504)  is necessary for 
the TJ localization of occludin, although detailed analysis of 
this domain remains to be performed. For example, mOc/d 
(445-474) was not concentrated at TJ (see Figs. 2 and 3 h). 
Association of Itght Junction Peripheral Proteins with 
the COOH-terminal Cytoplasmic Domain of Occludin 
Another possible function of the COOH-terminal cytoplas- 
mic domain (domain E) of occludin is its association with 
TJ peripheral proteins such as ZO-1, ZO-2, etc. To test this 
association in vitro, domain E  was expressed in E.  coli as 
a fusion protein with GST (GST-OcE). E. coli lysate was in- 
cubated with glutathione-Sepharose beads on a column, and 
after washing, the low salt alkali extract of junctional frac- 
tion isolated from chick liver was applied onto the column. 
After incubation and washing, the proteins associated with 
GST-OcE  coupled  to  glutathione-Sepharose  beads  were 
eluted with a solution containing glutathione, and were then 
resolved by SDS-PAGE. 
As shown in Fig. 4 a, lane 2, this in vitro binding assay 
revealed two major bands with molecular masses of 220 and 
160 kD bound to domain E of occludin.  The 220-kD band 
was  specifically recognized by anti-ZO-1  mAb (Fig.  4  a, 
lane 6). The molecular mass of the 160-kD band indicated 
that it would be related to  ZO-2,  a  ZO-l-binding protein 
identified in canines (Gumbiner et al., 1991).  Since an mAb 
recognizing chick ZO-2 was not available,  we prepared a 
high  salt extract from the membranes of cultured  MDBK 
cells, from which ZO-2 is recognized by the pAb R9989 pro- 
duced by Jesaitis and Goodenough (1994). Oecludin-binding 
proteins were recovered from the extract using the column 
system described above. Immunoblots of these proteins re- 
vealed that ZO-2, as well as ZO-1, were bound to domain 
E of occludin (Fig. 4 b). This suggests that the 160-kD band 
from the chick junctional fraction is the chick homologue of 
ZO-2. Furthermore, as shown in Fig. 4  b, a,-spectrin from 
the high  salt extract of MDBK cells was also specifically 
trapped by the GST-OcE beads. 
Sequences in the COOH-terminal Cytoplasmic 
Domain of Occludin Necessary for Association 
with ZO-1 
The question has naturally arisen whether the association of 
occludin  with  ZO-1  is  required  for TJ  localization of oc- 
cludin.  We attempted to narrow down the sequence neces- 
sary for the  association of occludin  with  ZO-1  from both 
COOH- and NH2-terminal sides,  and to evaluate whether 
or not this domain is included in or overlapped with the do- 
main E358/504, which is necessary for TJ localization ofoc- 
cludin. We expressed several GST-fusion proteins containing 
COOH- or NH2-terminal truncations of domain E in E. coli 
(Fig. 5). Using these fusion proteins and the extract of  junc- 
tional  fraction,  we  performed in  vitro  binding  studies  in 
which the amount of ZO-1 molecules bound to a fixed quan- 
tity of GST-fusion proteins was evaluated by immunoblot- 
ting. 
As shown in Fig. 6, all COOH-terminal truncated fusion 
proteins  (GST-OcE/dC474,  GST-OcE/dC444,  GST-OcE/ 
dC414,  and  GST-OcE/dc357)  exhibited  no  or  markedly 
weaker binding to ZO-1 than GST-OcE, indicating that the 
sequence necessary for the ZO-1 binding could not be nar- 
Oc-2 recognizes chick occludin but neither bovine nor human occludin,  whereas "1"8-754 crossreacts with both human and bovine ZO-I. 
(a and b) Conventional immunofluorescence microscopic  images of MDBK cells. The transiently expressed chick occlndin and bovine 
ZO-1 were coconcentrated at the eel-cell border. The cytoplasmic staining with anti-occludin mAb is specific, and this may be a result 
of  overexpression of  chick occludin. (c-f) Laser scan microscopic images of'1"84  cells. Optical sections at the level of  the junctional complex 
(c and d) and computer-generated cross-sectional images (e and f). The expressed chick occludin and human ZO-1 were precisely colocal- 
ized at the most apical region of lateral membranes (arrows). ap, the level of apical surface; ba, the level of basal membrane.  (g and h) 
Conventional  immunofluorescence  microscopic  images  of fibroblasts.  Most  of the  expressed  chick  occludin  was distributed  in the 
cytoplasm,  but some of them was colocalized with ZO-I at cell-cell contact sites. Bar,  10/~m. 
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main E of  oeeludin. (a) In vitro binding of  GST-OcE fusion protein 
to proteins in the low salt alkali extract of junctional fraction iso- 
lated from chick liver (IF extract).  Domain E of oecludin was ex- 
pressed in E. coli as a fusion protein with GST (GST-OcE),  and 
E. coli lysate was incubated  with glutathione-Sepharose  beads on 
a column.  After washing  and applieatiun  of JF extract onto the 
column, the proteins associated with GST-OcE were eluted with a 
solution containing glutathione.  Silver-stained  gel (lanes 1-4) and 
accompanying immunoblot with anti-ZO-1  mAb,  I'8-754 (lanes 
5-8) of  glutathione-eluate from GST column incubated with IF ex- 
tract (lanes I and 5), ghtathione-eluate from GST-OcE eolunm in- 
cubated with JF extract (lanes 2 and 6), ghtathione-eluate from 
GST-OcE column without the incubation with IF extract (lanes 3 
and 7), and JF extract (lanes 4 and 8). Comparison between lanes 
1, 2, and 3 revealed  that two major bands of •  220 and 160 kD 
bound to domain E  of occludin (arrowheads),  and immunoblot 
analyses  identified the former bands as ZO-1. The mobility of mo- 
lecular mass markers is shown at the left (200,  116, 97, 66, 45, and 
31 kD from the top). (b) In vitro binding of GST-OcE fusion pro- 
tein to proteins in the high salt extract of MDBK ceils.  Immuno- 
blots with anti-ZO-1 mAb, I"8-754 (lanes I and 2), anti-ZO-2 pAb, 
R9989 (lanes 3 and 4), and anti-u-spectrin pAb (lanes 5 and 6) of 
glutathione-eluate from GST beads incubated with MDBK extract 
(lanes 1, 3, and 5) and glutathione-eluate from GST-OeE beads in- 
cubatr.d with MDBK extract (lanes 2, 4, and 6). Note that ot-spec- 
trin and ZO-1/ZO-2  were specifically  trapped by domain E of oc- 
cludin. The mobility of  molecular mass markers is shown at the left 
(200 and  116 kD from the top). 
rowed down from the  COOH-terminal  side.  On the other 
hand,  the  NH2-terminal  truncated  fusion  proteins,  GST- 
OcE/dN358,  strongly bound to ZO-1, whereas the further- 
truncated  fusion  proteins,  GST-OcE/dN387,  showed  very 
poor binding. 
Therefore, this bidirectional strategy identified amino acid 
residues  358-504 (domain E358/504)  as the region neces- 
sary for the association of occludin with ZO-1. The same re- 
suits were obtained when the high salt extract from MDBK 
and "184 cells was applied onto the column (data not shown). 
This conclusion is similar to that of the analysis of sequences 
Figure 5.  GST-fusion proteins  containing normal or truncated do- 
main E of occludin. 
necessary for the TJ localization of occludin,  but in sharp 
contrast,  GST-OcE/d (445-474)  strongly bound to ZO-1. 
Finally,  to evaluate whether ZO-1  is associated with oc- 
cludin directly or indirectly, we performed the in vitro bind- 
ing studies between various GST-OcE mutant proteins and 
an MBP-ZO-1 fusion protein produced in E.  coli. As shown 
in Fig.  7, the MBP-ZO-1  fusion protein bound strongly to 
GST-OcE,  GST-OcE/dN358,  and  GST-OcE/d  (445-474), 
but  very  weakly  to  the  other  GST-OcE  mutant  proteins. 
These data indicated that ZO-1 directly associates with the 
domain E358/504 of occludin. 
Discussion 
In our previous study, we identified a  novel integral mem- 
brane protein with an apparent molecular mass of •65  kD 
called occludin, and showed by immunofluorescence and im- 
munoelectron microscopy that it is localized exclusively at 
TJ of various types of epithelial and endothelial cells (Furuse 
et al.,  1993). Preembedding electron microscopic immuno- 
labeling of isolated bile canaliculi with anti-occludin mAb 
characteristically  revealed  immunogold  particles  directly 
over the points of membrane fusion of TJ, suggesting that oc- 
cludin is a component of  the TJ strand. In this study, we dem- 
onstrated,  by  means  of transfection,  that  the  newly  syn- 
thesized  chick  full-length  occludin  was  delivered  to  and 
incorporated into preexisting TJ in human and bovine epithe- 
lial cells. Also in fibroblasts lacking TJ, the introduced chick 
occludin was occasionally localized at cell-cell contact sites, 
although it remains to be checked electron microscopically 
whether or not TJ-like structures are formed there.  Further 
analyses using these transfection  systems will lead us to a 
Figure 3. Subeellular distribution of c-myc-tagged fnll-length and truncated chick occludin in transient MDBK transfectants.  MDBK cells 
were transfected  with plasmids of mOc (a),  mOc/dC474 (b),  mOetdC444 (c),  mOc/dC414 (d),  mOc/dC357 (e),  mOctdN358 (f), 
mOc/dN387 (g), or mOo/d(445-474) (h), and were then immunofluorescently  stained with anti-c-myc mAb. Only in a andf intense signal 
was detected from the cell--cell border.  In the other transfectants,  the expressed  truncated occludin was concentrated at the cytoplasm, 
and it formed large  spheres.  Even in the transfectants  expressing  a large amount of mOc and mOc/dN358 products, the products were 
concentrated not only in TJ, but also in similar spheres in the cytoplasm (data not shown).  Bar,  10/zm. 
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cludin with ZO-1 in the low salt alkali extract of isolated junctional 
fraction from chick liver. Columns were constructed using normal 
or truncated GST-OcE fusion proteins (see Fig. 5). After applica- 
tion of the low salt alkali extract, proteins trapped by each column 
were elnted with a solution containing ghitathione. After each elu- 
ate was resolved by SDS-PAGE, the amount of GST-fusion protein 
and ZO-1 was evaluated by Coomassie brilliant blue staining (bot- 
tom)  and  immunoblotting  with  anti-ZO-1  mAb,  "18-754 (top), 
respectively. (Lane 1) GST-OcE; (lane 2) GST-OcE/dC357; (lane 
3)  GST-OcE/dN358;  (lane  4)  GST-OcE/dN387;  (lane 5)  GST; 
(lane  6)  GST-OcE/dC414;  (lane  7)  GST-OcE/dC444;  (lane  8) 
GST-OcE/dC474;  (lane  9)  GST-OcE/d(445-474).  Only  GST- 
OcE/dN358  (lane  3)  and  GST-OcE/d(445-474)  (lane  9)  were 
strongly bound to ZO-1 to the same extent as GST-OcE (lane 1 ). 
GST-OcE/dN387, GST-OcE/dC414, and GST-OeE/dC444  (lanes 
4, 6, and 7) appeared to weakly trap ZO-1. The mobility of  molecu- 
lar mass markers is shown at the left (66, 45, and 31 kD from the 
top). 
better understanding  how  the  cell  polarity  is  formed and 
maintained in epithelial and endothelial cells. 
In addition to the TJ localization mechanism, the isolation 
of occludin cDNA enabled us to analyze the interaction of 
occludin with TJ peripheral proteins at the molecular level. 
Based on the distance from the plasma membrane, TJ pe- 
ripheral proteins can be subclassified into  two categories 
(Anderson et al.,  1993; Citi, 1993). The first class includes 
ZO-1, which is localized in the immediate vicinity of mem- 
branes (Stevenson et al., 1986,  1989; Anderson et al., 1988; 
Itoh et al.,  1991,  1993).  Immunoprecipitation studies have 
shown that ZO-1 forms a protein complex with another pe- 
ripheral protein, ZO-2 (Gumbiner et al.,  1991; Jesaitis and 
Goodenough, 1994). Therefore, it is likely that ZO-2 is also 
localized just beneath the plasma membrane.  The  second 
class includes cingulin and the 7H6 antigen, which are local- 
ized more than 40 nm from the plasma membrane (Citi et 
al., 1988,  1993; Zhong et al,, 1993; Stevenson et al., 1989). 
In this study, we showed that the GST-fusion protein (GST- 
OcE)  of the  COOH-terminal  cytoplasmic domain  of oc- 
cludin (domain E) specifically associated at least with 220- 
Figure 7. Association of normal and truncated domain E of  occludin 
with MBP-ZO-1 fusion protein produced in E. coli.  Glutathione- 
conjugated beads were incubated with normal or truncated  GST- 
OcE fusion proteins (see Fig. 5). After washing followed by incuba- 
tion with the lysate from E. coil producing MBP-ZO-I fusion pro- 
tein, proteins trapped by beads were ehited with SDS-PAGE sample 
buffer. After each eluate was resolved by SDS-PAGE, the amount 
of GST-fusion protein and MBP-ZO-1 fusion protein was evaluated 
by Coomassie brilliant blue staining (bottom) and immunoblotting 
with anti-ZO-1  mAb,  I"8-109 (top), respectively. For Coomassie 
brilliant blue staining, one tenth or one fifth of the amount of each 
immunoblot  sample was used  in lanes  1-6 or  7-9, respectively. 
(Lane  1)  GST-OcE;  (lane  2)  GST-OcE/dC474;  (lane  3)  GST- 
OcE/dC357; (lane 4) GST-OcE/dN358; (lane 5) GST-OcE/dN387; 
(lane 6) GST; (lane 7) GST-OcE; (lane 8) GST-OcE/d(445-474); 
(lane 9) GST. Only GST-OcE/dN358 (lane 4) and GST-OcE/d(445- 
474) (lane 8) were strongly bound to MBP-ZO-1 fusion protein to 
the  same extent as GST-OcE (lanes 1 and  7).  GST-OcE/dC474 
(lane 2) appeared to weakly trap MBP-ZO-1. The mobility of mo- 
lecular mass markers is shown at the left (200, 116, 97, 66, 45, and 
31 kD from the top). 
and 160-kD bands among the various membrane peripheral 
proteins in the junctional fraction extract. Taking our immu- 
noblotting  data  into  consideration  together with previous 
data, we concluded that the two bands corresponded to ZO-1 
and ZO-2. Furthermore, we demonstrated that the MBP-ZO-1 
fusion protein directly bound to the domain E of occludin, 
at  least  in  vitro.  Therefore,  we  concluded  that  ZO-1  is 
directly bound to the domain E of occludin,  and that ZO-2 
may be associated with occludin through ZO-1. This conclu- 
sion is highly consistent with the notion that ZO-1 and ZO-2 
are localized just beneath the plasma membrane of TJ. 
We showed that spectrin tetramers are associated with ZO- 
1 at ~10-20 nm from their midpoint (Itoh et al., 1991). Also 
in  this  study,  spectrin  from MDBK cells was  specifically 
trapped by the GST-occludin column. Thus there may be a 
molecular linkage between occludin and actin filaments, as 
shown in Fig.  8,  since an intimate spatial relationship be- 
tween TJ and actin-based cytoskeletons has been observed 
(Madara,  1987).  The reason why occludin has not been so 
The Journal of Cell Biology, Volume 127,  1994  1624 Figure 8.  Schematic drawing of the possible molecular  architec- 
ture  of tight junctions.  The direct association between ZO-1 and 
a-spectrin was reported by Itoh et al. (1991) using the isolated junc- 
tional fraction. So far, immunoprecipitation experiments with anti- 
ZO-I antibodies from whole cell lysate have not detected this as- 
sociation (Gumbiner et al., 1991; Jesaitis and Goodenough,  1994). 
far identified in ZO-1 immunoprecipitates is not clear, but it 
may be partly caused by the insolubility of occludin against 
nonionic detergents and partly caused by the very low ex- 
pression level of occludin in cells. 
All the data obtained from two series of experiments with 
various domain E deletion mutants are summarized in Fig. 
9. The sequences in domain E (amino acid residues 250-504) 
necessary  for  the  TJ  localization  or  ZO-1  association  of 
occludin were narrowed down from COOH- and NH2-ter- 
minal sides. Neither TJ localization- nor ZO-1 association- 
responsible sequences could be defined from COOH-termi- 
nal side, whereas both sequences were narrowed down as far 
as  amino  acid  residue  358  from  the  NH2-terminal  side. 
This  coincidence  led  to  the  speculation  that  the  ZO-1- 
binding ability of occludin is required for its TJ localization. 
Actually, as far as we examined in a combination of in vivo 
transfection experiments and in vitro binding assays, all dele- 
tion mutants with significantly reduced ZO-l-binding ability 
lacked TJ-localization ability. However, the converse was not 
so.  All  deletion  mutants  bearing  sufficient  ZO-l-binding 
ability did not bear TJ-localization ability. For example, an 
occludin mutant lacking amino acid residues 445-474 bound 
to ZO-1 in vitro, but was not concentrated at TJ. Therefore, 
we speculate that the association of not only ZO-1, but also 
other factors to the 358-504 aa sequence of domain E  (do- 
main E358/504),  is required for the localization of occludin 
at TJ. At present, it is not clear why ZO-1 association is at 
least required for the TJ localization. It may be required for 
the  targeting  of occludin  to  membranes,  assembly of oc- 
cludin  into  TJ  strands,  or retention  of occludin on mem- 
branes.  These should be clarified in the near future. 
Two distinct types of small rab GTPases, rabl3 and rab3B, 
are reportedly concentrated at TJ in epithelial  cells (Zah- 
raoui et al., 1994; Weber et al., 1994). Considering that the 
rab  family members are  involved in  membrane traffic  in 
general (Bourne,  1988;  Goud and McCaffrey, 1991;  Zerial 
and Stenmark,  1993), it is likely that these rabl3 and rab3B 
play an important role in the assembly of TJ, that is, the tar- 
geting of occludin.  Therefore, we should evaluate whether 
or not these small rab GTPases can interact with the domain 
Figure  9.  Comparison  of the  results  obtained  from transfection 
studies with those from in vitro binding studies. The constructs that 
were concentrated at tight junctions are marked with (+), and those 
that showed strong, weak, and no binding affinity to ZO-1 are repre- 
sented by S, W, and N, respectively. Of course,  it is possible that 
some of the constructs marked with (-) exhibit "weak  ~ localization 
at tight junctions,  which was hard to detect. 
E  of occludin directly or indirectly, and we should further 
search for other factors that regulate the TJ localization of 
occludin by interacting with domain E. Also, we should ob- 
tain information about the functions of the other cytoplasmic 
domain of occludin (domains A  and C),  although they are 
somewhat shorter than the domain E. Identification of cyto- 
plasmic proteins directly associated with occludin and as- 
signment of their binding domains on occludin molecules 
will give us a wealth of information for the future studies, 
not only on the structure,  but also on the functions of tight 
junctions. It is possible, for example, that some of the dele- 
tion occludin mutants used in this study behave as dominant 
negative mutants  and  interfere with the  functions  of tight 
junctions.  We believe that further analyses of the cytoplas- 
mic domains of occludin will lead us to a better understand- 
ing of the structure and functions of TJ at the molecular level. 
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